| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 681231 | Boronic acid, [1-[[3-(1-naphthalenyl)-2-[(4-morpholinyl carbonyl)amino]-1-oxopropyl]amino]-3-methylbutyl]-, D-(S)- | 0.0145667015252499 | -0.055248041 |
| NSC 682836 | Propanimidoyl chloride, N-[[[[2-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- | 0.0145667015252499 | 0.17275329 |
| NSC 689222 | Null | 0.01456670152525 | 0.11078864 |
| NSC 695164 | 2-Propen-1-one, 1-(2-benzimidazolyl)-3-(4-nitrophenyl)- | 0.01456670152525 | 0.094194561 |
| NSC 715522 | Null | 0.01456670152525 | 0.21686992 |
| NSC 722779 | dabequine | 0.01456670152525 | 0.41554359 |
| NSC 724827 | 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline | 0.01456670152525 | 0.17179035 |
| NSC 725202 | Null | 0.01456670152525 | 0.095028608 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.01456670152525 | 0.032161772 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.01456670152525 | 0.066848859 |